Our findings derived from sophisticated bioinformatics data re‐analyses, genetic or pharmacological manipulations in vitro, preclinical cellular/animal models, and clinical samples provide ample experimental support for LIF‐SE‐driven CSC regulatory model in HNSCC. The gene discussed is LIF; the disease is head and neck squamous cell carcinoma.